Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Lymphadenopathy, Neoplasm malignant, Platelet count, Splenomegaly, Thrombocytopenia
Clinical narrative: Right after the first booster right away she got thrombocytopenia, platelets were lowered; diagnosed with a rare uncurable lymphoma called 'waldensprom macroglobulinemia lymphoplasmacytic lymphoma; States her lymph nodes and her spleen is enlarged; States her lymph nodes and her spleen is enlarged; developed cancer on her leg which was removed; This is a spontaneous report received from a Consumer or other non HCP from medical information team.  A 75-year-old female patient received BNT162b2 (COMIRNATY), on 12Nov2021 as dose 3 (booster), single (Lot number: FG3527) at the age of 73 years for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: BNT162b2 (DOSE 1, SINGLE, Batch/lot number: EN6198), administration date: 04Mar2021, when the patient was 73-year-old, for COVID-19 immunization; BNT162b2 (DOSE 2, SINGLE, Lot: EN6208), administration date: 25Mar2021, when the patient was 73-year-old, for COVID-19 immunization. The following information was reported: NEOPLASM MALIGNANT (medically significant) with onset 18Nov2021, outcome "unknown", described as "developed cancer on her leg which was removed"; THROMBOCYTOPENIA (medically significant), outcome "unknown", described as "Right after the first booster right away she got thrombocytopenia, platelets were lowered"; WALDENSTROM'S MACROGLOBULINAEMIA (medically significant), outcome "unknown", described as "diagnosed with a rare uncurable lymphoma called 'waldensprom macroglobulinemia lymphoplasmacytic lymphoma"; LYMPHADENOPATHY (non-serious), SPLENOMEGALY (non-serious), outcome "unknown" and all described as "States her lymph nodes and her spleen is enlarged". The patient underwent the following laboratory tests and procedures: Platelet count: lowered. Therapeutic measures were taken as a result of neoplasm malignant. Additional information: States 6 days after receiving pfizer covid booster, she developed cancer on her leg which was removed. States a few months ago she was diagnosed with a rare uncurable lymphoma called 'waldensprom macroglobulinemia lymphoplasmacytic lymphoma. States her lymph nodes and her spleen is enlarged. States she has also had a couple of thrombocyopenia flareups since receving the vaccine. States she reported this in Mar2021 and received a form which she completed and sent back. States there was no data at that time.  She received the first shot in Mar2021, the first Pfizer Vaccine shot, confirmed as Covid 19 Vaccine and at the time right after developed as spelled out and confirmed, thrombocytopenia. She has heard some people have developed this after the vaccine, no additional details regarding these people. This is when platelet count goes down and can develop blood clots. Right after the first booster right away she got thrombocytopenia, platelets were lowered.  She also developed cancer on the leg. She got the shot in left arm and cancer developed in left leg. 3 months ago she was diagnosed with a rare uncommon incurable lymphoma which is attributed to thrombocytopenia.